WHEREOn Zoom: http://bit.ly/3-3rally Live streamed on the Start SMART Facebook page WHENWednesday, March 3 at 10:30am WHATAdvocates from across New York State are holding a rally at 10:30 am to kick off the marijuana justice virtual day of action calling on the legislature and Gov. Cuomo to legalize cannabis by passing the Marijuana Regulation and Taxation Act (S.854/A.1248) […]
Let’s face it, being stuck inside with a lack of scenery changes makes it a whole lot harder to switch off at the end of the day. We’re all dealing with it to some extent, and lots of us seem to have turned to marijuana to fix that difficulty.
According to a report by Ganja Goddess, a delivery platform, cannabis products that have marketed specifically for sleep have jumped 635%. Now this is a very vague descriptor because it can detail anything from CBD oils to actual marijuana flower, but still, that’s a remarkable jump.
The science behind marijuana helping sleep is very disputed. Many in the sleep field, including Matthew Walker, author of the bestselling book Why We Sleep, argues that due to its suppression of the REM (rapid eye movement) stage, marijuana causes a less restful sleep. Of course, this is ideal for those trying to prevent habitual nightmares or PTSD bouts, but those who don’t suffer from these issues could be delivering a less restful sleep, despite it being easier to doze off at first.
Ganja Goddess also found a 275% increase in revenue on April 20 of last year (4/20) and a 200% increase on Cyber Monday.
Read the original story at Ganjapreneur.
DPA Calls for House Bill 12 to be the Vehicle for Legalization in New Mexico Santa Fe, NM – With the New Mexico House of Representatives Voting in Favor of Cannabis Legalization today on a 39-31 vote, Emily Kaltenbach, Senior Director for Resident States and New Mexico for the Drug Policy Alliance, released the following […]
House Bill 1100, which is backed by Governor Noem and other legislative leaders, pushes back the timeline from this summer until early 2022.
The post South Dakota: House Members Approve Legislation to Delay Implementation of Voter-Approved Medical Cannabis Law appeared first on NORML.
“[T]he implementation of medical marijuana laws (MMLs) and recreational marijuana laws (RMLs) reduced morphine milligram equivalents per enrollee by seven percent and 13 percent, respectively.”
The post Study: Enactment of Marijuana Legalization Laws Associated with Reductions in Opioid Prescribing Patterns appeared first on NORML.
The measure, approved by a 21 to 8 vote, would permit patients and caregivers 19 years and older to possess “70 daily dosages of medical cannabis” at a time.
The post Alabama: Senate Lawmakers Approve Medical Marijuana Legislation appeared first on NORML.
“The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment. Thus, cannabinoids may be considered for FMS treatment.”
The post Study: Cannabis Mitigates Symptoms in Patients with Treatment-Resistant Fibromyalgia appeared first on NORML.
Albany – The following statement can be attributed to the Drug Policy Alliance, New York Medical Cannabis Industry Association and New York Cannabis Growers & Processors Association in support of key policies in the Marijuana Reform & Taxation Act (MRTA). The announced amendments for Governor Cuomo’s Cannabis Regulation and Taxation Act are a step in the […]
An article at The Denver Post calls for Democrats to follow science and decide on a cap on THC potency.
These concentrates are not plant material rolled in a joint. They are produced by soaking marijuana buds in chloroform, butane, and propane. Those chemicals extract and concentrate the THC from the plant into what’s called “wax” or “shatter.” With a crack pipe and a butane torch, users vaporize and inhale that THC-rich shatter. Or, as a change of pace, at a Colorado dispensary a user can just buy a 70% THC anal or vaginal suppository and insert that. These concentrates are what cause harm, and right now there are zero limits on their potency. Zero.
So what? Well, studies published in the internationally renowned medical journal The Lancet Psychiatry conclude that using products with 15% THC or higher triples the risk of psychosis, and daily use of such products quintuples that risk. In fact, 56 scientific studies have confirmed high potency THC’s connection to psychosis. In addition, a study published in The Journal of American Medicine in 2020 concluded that high potency THC “was associated with significant increases” in addiction and mental health disorders (like depression and anxiety). High potency THC is addictive. In 2017 The Journal of Psychiatric Research published a study concluding that THC addiction is “significantly associated with suicide” (especially for teens and veterans). This is the science that drove a Washington state legislator and public health professional to conclude THC concentrates have created “one of the largest emerging health crises of our time.”
In a previous article, we had looked into this argument with the conclusion that there simply needs to be much more research into what designates “too much” THC. Most can agree with a need for regulation, but where those numbers reside is up to debate. The author of the Denver Post article also backs this opinion, concluding that whatever the number, we simply follow the science.
Vermont, for instance, has created a cap of flower at 30% THC and concentrates at 60%. It will be fascinating watching this unfold and see the results come in over time.
Read full article at The Denver Post
New York, NY – Today, the Drug Policy Alliance announced the launch of a major new initiative—Uprooting the Drug War—with the release of a series of reports and interactive website that aim to expose the impact of the war on drugs beyond arrest and incarceration. The project is designed to engage activists across sectors and […]
